Erica Villa

33PUBLICATIONS
112CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modellingCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|May 04, 2026
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Before and After Liver Transplantation: A Systematic Review.

|Apr 14, 2026
Intrinsic Tumor Aggressiveness Dictates Hypoxia-Driven Metabolic Programs in Hepatocellular Carcinoma.

Fabiola Milosa, Nicolò Giglioli, Rosina Maria Critelli

|Mar 25, 2026
Predicting the Risk of Decompensation in Patients With Cirrhosis: A Validated Machine Learning Approach.

Philip J Johnson, Anton Kalyuzhnyy, Arturas Grauslys

|Jan 07, 2026
Sex Hormones and the Liver: Implications for Disease Progression and Hormonal Therapy.

Nora Cazzagon, Martina Gambato, Maurizia Rossana Brunetto

|Aug 05, 2025
CNNM4: a ferroptotic vulnerability in cholangiocarcinoma.

Erica Villa

|Oct 26, 2024
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment.

Rosina Maria Critelli, Federico Casari, Alberto Borghi

Pageof 6

Frequent Collaborators

6 joint publications

Filippo Schepis

5 joint publications

Rosina Maria Critelli

5 joint publications

Fabiola Milosa

4 joint publications

Grazia Serino